Clinical trial
Efficacy of Temocillin in Urinary Tract Infection Due to ESBL Producing and AmpC Hyperproducing Enterobacteriaceae
NCT02681263 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Temocillin in Urinary Tract Infection Due to ESBL Producing and AmpC Hyperproducing Enterobacteriaceae
- Lead sponsor
- University Hospital, Grenoble
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- April 30, 2016
- Completion date
- September 30, 2018
- Enrollment
- 25 (actual)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.